Rigel Pharmaceuticals | RIGL - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
Agenus USD 18.74M 16.26M 2026-06
Amgen USD 13.99B 1.95B 2026-06
Anika Therapeutics USD 38.41M 2.61M 2026-06
Arrowhead Research USD 19.68M 127.85M 2026-06
AstraZeneca USD 4.89B 2.67B 2026-06
BioMarin Pharmaceutical USD 874M 1.35B 2026-06
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Celldex Therapeutics USD 47.45M 11.72M 2026-06
Daiichi Sankyo JPY 449.81B 92.35B 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Heron Therapeutics USD 20.72M 5.4M 2026-06
Intrexon USD 9.34M 1.77M 2024-06
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
Ligand Pharmaceuticals USD 1.01B 891.62M 2026-06
MacroGenics USD 113.91M 47.39M 2026-06
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Pfizer USD 976M 727M 2026-06
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Ultragenyx Pharmaceutical USD 125M 50M 2026-06
Veracyte USD 299.52M 36.38M 2026-06